Evidence map›Paper›PMID 41028714›Full record

ArticleNature communications2025

Regulation of NSL by TAF4A is critical for genome stability and quiescence of muscle stem cells.

Angelina M Georgieva, Krishna Sreenivasan, Dong Ding, Clementine Villeneuve, Sara A Wickström, Stefan Günther, Carsten Kuenne, Ulrich Gärtner, Xinyue Guo, Yonggang Zhou and 2 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Angelina M GeorgievaDepartment of Cardiac Development and Remodeling, Max Planck Institute for Heart and Lung Research, 61231, Bad Nauheim, Germany.ORCID http://orcid.org/0000-0002-3215-427X
Krishna SreenivasanDepartment of Cardiac Development and Remodeling, Max Planck Institute for Heart and Lung Research, 61231, Bad Nauheim, Germany.
Dong DingDepartment of Cardiac Development and Remodeling, Max Planck Institute for Heart and Lung Research, 61231, Bad Nauheim, Germany.
Clementine VilleneuveDepartment of Cell and Tissue Dynamics, Max Planck Institute for Molecular Biomedicine, 48149, Münster, Germany.
Sara A WickströmDepartment of Cell and Tissue Dynamics, Max Planck Institute for Molecular Biomedicine, 48149, Münster, Germany.ORCID http://orcid.org/0000-0001-6383-6292
Stefan GüntherDepartment of Cardiac Development and Remodeling, Max Planck Institute for Heart and Lung Research, 61231, Bad Nauheim, Germany.ORCID http://orcid.org/0000-0002-5594-4549
Carsten KuenneDepartment of Cardiac Development and Remodeling, Max Planck Institute for Heart and Lung Research, 61231, Bad Nauheim, Germany.ORCID http://orcid.org/0000-0001-8013-5906
Ulrich GärtnerInstitute for Anatomy and Cell Biology, University of Giessen, 35392, Giessen, Germany.
Xinyue GuoDepartment of Cardiac Development and Remodeling, Max Planck Institute for Heart and Lung Research, 61231, Bad Nauheim, Germany.
Yonggang ZhouDepartment of Cardiac Development and Remodeling, Max Planck Institute for Heart and Lung Research, 61231, Bad Nauheim, Germany.
Xuejun YuanDepartment of Cardiac Development and Remodeling, Max Planck Institute for Heart and Lung Research, 61231, Bad Nauheim, Germany. xuejun.yuan@mpi-bn.mpg.de.ORCID http://orcid.org/0000-0002-1080-8973
Thomas BraunDepartment of Cardiac Development and Remodeling, Max Planck Institute for Heart and Lung Research, 61231, Bad Nauheim, Germany. thomas.braun@mpi-bn.mpg.de.ORCID http://orcid.org/0000-0002-6165-4804

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) CPI Excellence ClusterDeutsche Forschungsgemeinschaft (German Research Foundation) SFB 1213, TP B02Deutsche Forschungsgemeinschaft (German Research Foundation) SFB 1231, TP A02Deutsche Forschungsgemeinschaft (German Research Foundation) SFB 1531, TP B08Deutsche Forschungsgemeinschaft (German Research Foundation) SFB TRR 267, TP A05Hessisches Ministerium für Wissenschaft und Kunst (Hessen State Ministry of Higher Education, Research and the Arts) LOEWE iCANx
6 · The paper itself

Abstract

Acetylation of lamin A/C by the non-specific lethal complex, containing MOF and KANSL2, is instrumental for maintaining nuclear architecture and genome stability, but the mechanisms controlling expression of its components in different cell types are poorly characterized. Here, we show that TAF4A, primarily known as a subunit of TFIID, forms a complex with the heterotrimeric transcription factor NF-Y and is critical for cell type-specific regulation of Kansl2 in muscle stem cells. Inactivation of Taf4a reduces expression of Kansl2 and alters post-translational modification of lamin A/C, thereby decreasing nuclear stiffness, which disrupts the nuclear architecture and results in severe genomic instability. Reduced expression of Kansl2 in Taf4a-mutant muscle stem cells changes expression of numerous genes involved in chromatin regulation. The subsequent loss of heterochromatin, in combination with pronounced genomic instability, activates muscle stem cells but impairs their proliferation, which depletes the stem cell pool and abolishes skeletal muscle regeneration. We conclude that TAF4A-NF-Y-dependent transcription regulation safeguards heterochromatin and genome stability of muscle stem cells via the non-specific lethal complex.

Indexed as

Genomic InstabilityNuclear ProteinsStem CellsTATA-Binding Protein Associated FactorsTranscription Factor TFIIDAnimalsCell ProliferationGene Expression RegulationHumansMiceMuscle, SkeletalNuclear ProteinsTATA-Binding Protein Associated FactorsTranscription Factor TFIID

Identifiers

PMID41028714
PMCPMC12484798

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.